{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:28:34Z","timestamp":1791581314091,"version":"4.3.4"},"reference-count":154,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009139","name":"German Center for Infection Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Miltenyi Biotec GmbH"},{"name":"Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases"},{"DOI":"10.13039\/501100008001","name":"University of Cologne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008001","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Actelion"},{"name":"Amplyx"},{"name":"Arsanis"},{"name":"Astellas"},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Basilea"},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010643","name":"Cidara","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010643","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Da Volterra"},{"name":"F2G"},{"DOI":"10.13039\/100005564","name":"Gilead","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GSK"},{"name":"anssen Pharmaceuticals"},{"name":"Leeds University"},{"name":"Matinas"},{"DOI":"10.13039\/100015237","name":"Medicines Company","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015237","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007050","name":"MedPace","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007050","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Melinta Therapeutics"},{"name":"Menarini Ricerche"},{"name":"Merck\/MSD"},{"name":"Miltenyi"},{"name":"Paratek Pharmaceuticals"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004219","name":"PSI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004219","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Rempex"},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scynexis"},{"name":"Seres Therapeutics"},{"name":"Summit"},{"name":"Tetraphase"},{"name":"Vical"},{"name":"IQVIA"},{"name":"Innovative Medicines Initiative Joint"},{"name":"European Union\u2019s Seventh Framework Programme"},{"name":"EFPIA companies\u2019"},{"DOI":"10.13039\/100004343","name":"3M","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004343","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DaVolterra"},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MaaT Pharma"},{"name":"Morphochem"},{"name":"Organobalance"},{"name":"Seres Therapeutics"},{"name":"Uniklinik Freiburg\/Kongress und Kommunikation"},{"name":"Beckmann"},{"name":"BioMerieux"},{"name":"Bruker Daltonics"},{"name":"Cepheid"},{"DOI":"10.13039\/100015160","name":"Hologic","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015160","id-type":"DOI","asserted-by":"crossref"}]},{"name":"r-biopharm"},{"DOI":"10.13039\/501100004830","name":"Siemens","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004830","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SepcificTechnologies"},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Uniklinik Freiburg \/ Kongress und Kommunikation"},{"name":"Akademie f\u00fcr Infektionsmedizin"},{"name":"Universit\u00e4t Manchester, Deutsche Gesellschaft f\u00fcr Infektiologie"},{"name":"\u00c4rztekammer Nordrhein"},{"name":"Uniklinik Aachen"},{"name":"Back Bay Strategies"},{"name":"Deutsche Gesellschaft f\u00fcr Innere Medizin"},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.cmi.2019.04.024","type":"journal-article","created":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T20:05:43Z","timestamp":1556395543000},"page":"1200-1212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":314,"title":["Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis"],"prefix":"10.1016","volume":"25","author":[{"given":"P.","family":"Koehler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Stecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.A.","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.G.T.","family":"Vehreschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bohlius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Wisplinghoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Vehreschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2019.04.024_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1469-0691.12038","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures","volume":"18","author":"Cuenca-Estrella","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10096-014-2230-8","article-title":"Candidemia in the intensive care unit: analysis of direct treatment costs and clinical outcome in patients treated with echinocandins or fluconazole","volume":"34","author":"Heimann","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jcrc.2012.07.011","article-title":"Attributable costs of patients with candidemia and potential implications of polymerase chain reaction-based pathogen detection on antifungal therapy in patients with sepsis","volume":"28","author":"Bloos","year":"2013","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.cmi.2019.04.024_bib5","first-page":"360","article-title":"Excess mortality, length of stay and cost attributable to candidaemia","volume":"59","author":"Hassan","year":"2009","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib6","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1473-3099(15)70006-X","article-title":"British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases","volume":"15","author":"Schelenz","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib8","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1086\/313749","article-title":"Practice guidelines for the treatment of candidiasis. infectious diseases society of america","volume":"30","author":"Rex","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jhin.2009.01.008","article-title":"Epidemiology of nosocomial bloodstream infections in Estonia","volume":"71","author":"Mitt","year":"2009","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib11","first-page":"27","article-title":"Bloodstream infections in adults: importance of healthcare-associated infections","volume":"56","author":"Valles","year":"2008","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103916","article-title":"Nosocomial candidemia; risk factors and prognosis revisited; 11 years experience from a Norwegian secondary hospital","volume":"9","author":"Berdal","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2019.04.024_bib13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1159\/000320305","article-title":"Incidence, etiology and risk factors associated with mortality of nosocomial candidemia in a tertiary care hospital in Istanbul, Turkey","volume":"19","author":"Erdem","year":"2010","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.cmi.2019.04.024_bib14","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1017\/S0950268809991531","article-title":"Epidemiology of nosocomial candidaemia in a university hospital: a 12-year study","volume":"138","author":"Gurcuoglu","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib15","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1469-0691.2007.01812.x","article-title":"Changing pattern of candidaemia 2001\u20132006 and use of antifungal therapy at the University Hospital of Vienna, Austria","volume":"13","author":"Presterl","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib16","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1128\/JCM.01998-13","article-title":"Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain","volume":"51","author":"Bassetti","year":"2013","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.04.024_bib17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/380637","article-title":"Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991\u20132000","volume":"38","author":"Marchetti","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib18","doi-asserted-by":"crossref","DOI":"10.2807\/ese.18.24.20505-en","article-title":"No increase in primary nosocomial candidemia in 682 German intensive care units during 2006 to 2011","volume":"18","author":"Meyer","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2019.04.024_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1439-0507.2011.02044.x","article-title":"Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006\u20132008)","volume":"55","author":"Tortorano","year":"2012","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.04.024_bib20","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1128\/JCM.02566-12","article-title":"Nationwide study of candidemia, antifungal use, and antifungal drug resistance in Iceland, 2000 to 2011","volume":"51","author":"Asmundsdottir","year":"2013","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.04.024_bib21","doi-asserted-by":"crossref","first-page":"E218","DOI":"10.1111\/1469-0691.12111","article-title":"Candidaemia in Sweden: a nationwide prospective observational survey","volume":"19","author":"Ericsson","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib22","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3201\/eid0908.030069","article-title":"Candidemia in Finland, 1995\u20131999","volume":"9","author":"Poikonen","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/myc.12535","article-title":"Differences in epidemiology of candidaemia in the Nordic countries - what is to blame?","volume":"60","author":"Hesstvedt","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.04.024_bib24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/CCM.0b013e318206c1ca","article-title":"Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study","volume":"39","author":"Kett","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cmi.2019.04.024_bib25","doi-asserted-by":"crossref","first-page":"E343","DOI":"10.1111\/1469-0691.12212","article-title":"Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme","volume":"19","author":"Arendrup","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/1471-2334-10-312","article-title":"Secular trend in candidemia and the use of fluconazole in Finland, 2004\u20132007","volume":"10","author":"Poikonen","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijantimicag.2006.01.002","article-title":"Candidaemia in Europe: epidemiology and resistance","volume":"27","author":"Tortorano","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2019.04.024_bib28","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13756-016-0132-5","article-title":"First hospital outbreak of the globally emerging Candida auris in a European hospital","volume":"5","author":"Schelenz","year":"2016","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.cmi.2019.04.024_bib30","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/cid\/cis697","article-title":"Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008\u20132011","volume":"55","author":"Cleveland","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib31","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/JCM.40.4.1298-1302.2002","article-title":"Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study","volume":"40","author":"Diekema","year":"2002","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.04.024_bib32","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/JCM.42.4.1519-1527.2004","article-title":"Incidence of bloodstream infections due to Candida species and in\u00a0vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program","volume":"42","author":"Hajjeh","year":"2004","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.04.024_bib33","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1086\/313450","article-title":"The epidemiology of candidemia in two United States cities: results of a population-based active surveillance","volume":"29","author":"Kao","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib34","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1128\/JCM.43.4.1829-1835.2005","article-title":"Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003","volume":"43","author":"Almirante","year":"2005","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.04.024_bib35","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.eimc.2010.12.003","article-title":"Candidemias: multicentre analysis in 16 hospitals in Andalusia (Spain)","volume":"29","author":"Rodriguez-Hernandez","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.cmi.2019.04.024_bib36","doi-asserted-by":"crossref","first-page":"O245","DOI":"10.1111\/1469-0691.12380","article-title":"Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain","volume":"20","author":"Puig-Asensio","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib37","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s00134-017-4743-y","article-title":"The risk and clinical outcome of candidemia depending on underlying malignancy","volume":"43","author":"Lortholary","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2019.04.024_bib38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trial"},{"key":"10.1016\/j.cmi.2019.04.024_bib39","series-title":"Meta-analysis in Stata: an updated collection from the Stata journal","author":"Palmer T","year":"2016"},{"key":"10.1016\/j.cmi.2019.04.024_bib40","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/sim.1187","article-title":"How should meta-regression analyses be undertaken and interpreted?","volume":"21","author":"Thompson","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.cmi.2019.04.024_bib41","series-title":"World population prospects: the 2017 revision","author":"United Nations","year":"2017"},{"key":"10.1016\/j.cmi.2019.04.024_bib42","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/JCM.43.1.284-292.2005","article-title":"Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III","volume":"43","author":"Tavanti","year":"2005","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.04.024_bib43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.riam.2016.04.007","article-title":"Multiplex PCR designed to differentiate species within the Candida glabrata complex","volume":"34","author":"Dudiuk","year":"2017","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.cmi.2019.04.024_bib44","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2217\/fmb-2017-0241","article-title":"Identification of Candida glabrata complex species: use of Vitek MS((R)) RUO & Bruker ClinproTools((R))","volume":"13","author":"Hou","year":"2018","journal-title":"Future Microbiol"},{"key":"10.1016\/j.cmi.2019.04.024_bib45","series-title":"World population prospects: the 2017 revision","author":"United Nations DoEaSA","year":"2017"},{"key":"10.1016\/j.cmi.2019.04.024_bib46","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s00134-007-0865-y","article-title":"Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome","volume":"34","author":"Bougnoux","year":"2008","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2019.04.024_bib47","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10096-007-0316-2","article-title":"Candidemia in immunocompromised and immunocompetent critically ill patients: a prospective comparative study","volume":"26","author":"Dimopoulos","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib48","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1439-0507.2007.01366.x","article-title":"Risk factors for candidaemia in critically ill patients: a prospective surveillance study","volume":"50","author":"Jorda-Marcos","year":"2007","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.04.024_bib49","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1053\/jcrc.2002.35815","article-title":"Systemic candidiasis in intensive care units: a multicenter, matched-cohort study","volume":"17","author":"Leleu","year":"2002","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.cmi.2019.04.024_bib50","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/CCM.0b013e31819efac0","article-title":"Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005\u20132006)","volume":"37","author":"Leroy","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cmi.2019.04.024_bib51","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s15010-013-0432-0","article-title":"Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project)","volume":"41","author":"Montagna","year":"2013","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2019.04.024_bib52","doi-asserted-by":"crossref","first-page":"E71","DOI":"10.1016\/j.cmi.2015.05.019","article-title":"Variable incidence of candidemia in patients admitted to ICUs or medical wards of large tertiary-care Italian hospitals","volume":"21","author":"Tascini","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib53","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jhin.2004.01.017","article-title":"Candidosis in the intensive care unit: a 20-year survey","volume":"57","author":"Tortorano","year":"2004","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib54","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1469-0691.2008.02653.x","article-title":"Candidaemia: incidence, risk factors, characteristics and outcomes in immunocompetent critically ill patients","volume":"15","author":"Vardakas","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib55","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/myc.12470","article-title":"Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study","volume":"59","author":"Tadec","year":"2016","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.04.024_bib56","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3855\/jidc.7970","article-title":"Surveillance and characterization of Candida bloodstream infections in a Serbian tertiary care hospital","volume":"10","author":"Stojanovic","year":"2016","journal-title":"J\u00a0Infect Developing Countries"},{"key":"10.1016\/j.cmi.2019.04.024_bib57","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s15010-016-0951-6","article-title":"CAND-LO 2014\u201315 study: changing epidemiology of candidemia in Lombardy (Italy)","volume":"44","author":"Prigitano","year":"2016","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2019.04.024_bib58","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s15010-015-0845-z","article-title":"Epidemiology, clinical characteristics, and outcome of candidemia in a tertiary referral center in Italy from 2010 to 2014","volume":"44","author":"Barchiesi","year":"2016","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2019.04.024_bib59","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1556\/030.62.2015.3.9","article-title":"Significance of yeasts in bloodstream infection: epidemiology and predisposing factors of candidaemia in adult patients at a university hospital (2010\u20132014)","volume":"62","author":"Pongracz","year":"2015","journal-title":"Acta Microbiol Immunol Hungar"},{"key":"10.1016\/j.cmi.2019.04.024_bib60","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s40520-014-0251-x","article-title":"Epidemiology and outcome of nosocomial candidemia in elderly patients admitted prevalently in medical wards","volume":"27","author":"Luzzati","year":"2015","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.cmi.2019.04.024_bib61","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/256580","article-title":"Candida bloodstream infections in Italy: changing epidemiology during 16 Years of surveillance","author":"Caggiano","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.cmi.2019.04.024_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127534","article-title":"Clinical and therapeutic aspects of candidemia: a five year single centre study","volume":"10","author":"Bassetti","year":"2015","journal-title":"Plos One"},{"key":"10.1016\/j.cmi.2019.04.024_bib63","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/myc.12349","article-title":"Epidemiology of candidaemia in a tertiary care university hospital: 10-year experience with 381 candidaemia episodes between 2001 and 2010","volume":"58","author":"Alp","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.04.024_bib64","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11046-014-9786-9","article-title":"Candidaemia observed at a university hospital in milan (Northern Italy) and review of published studies from 2010 to 2014","volume":"178","author":"Milazzo","year":"2014","journal-title":"Mycopathologia"},{"key":"10.1016\/j.cmi.2019.04.024_bib65","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3109\/00365548.2014.900190","article-title":"Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period","volume":"46","author":"Marti-Carrizosa","year":"2014","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib66","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/myc.12209","article-title":"An investigation of Candida species isolated from blood cultures during 17 years in a university hospital","volume":"57","author":"Kazak","year":"2014","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.04.024_bib67","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/13693786.2012.686673","article-title":"Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade","volume":"51","author":"Parmeland","year":"2013","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2019.04.024_bib68","first-page":"64","article-title":"Emerging trends in candidemia: a higher incidence but a similar outcome","volume":"65","author":"Fortun","year":"2012","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib69","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jhin.2010.09.026","article-title":"Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008","volume":"77","author":"Ortega","year":"2011","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib70","doi-asserted-by":"crossref","first-page":"e759","DOI":"10.1016\/j.ijid.2011.06.006","article-title":"Epidemiology, clinical characteristics, and outcome of candidemia: experience in a tertiary referral center in the UK","volume":"15","author":"Das","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024198","article-title":"Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy","volume":"6","author":"Bassetti","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2019.04.024_bib72","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1080\/00365540903022824","article-title":"Nosocomial candidaemia in a Finnish tertiary care centre during 1987\u20132004","volume":"41","author":"Poikonen","year":"2009","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib73","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10096-007-0448-4","article-title":"A\u00a0first Portuguese epidemiological survey of fungaemia in a university hospital","volume":"27","author":"Costa-de-Oliveira","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib74","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.diagmicrobio.2007.01.005","article-title":"Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals","volume":"58","author":"Bassetti","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib75","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1439-0507.2006.01187.x","article-title":"Nosocomial bloodstream infections associated with Candida species in a Turkish University Hospital","volume":"49","author":"Yapar","year":"2006","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.04.024_bib76","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1469-0691.2005.01310.x","article-title":"Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital","volume":"12","author":"Bedini","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib77","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1600-0463.2006.apm_359.x","article-title":"Epidemiology of candidemia in a Turkish tertiary care hospital","volume":"114","author":"Bakir","year":"2006","journal-title":"APMIS"},{"key":"10.1016\/j.cmi.2019.04.024_bib78","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/qjmed\/hcl087","article-title":"Candidaemia in a large teaching hospital: a clinical audit","volume":"99","author":"Aliyu","year":"2006","journal-title":"QJM"},{"key":"10.1016\/j.cmi.2019.04.024_bib79","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1086\/502582","article-title":"Secular trends of candidemia in a large tertiary-care hospital from 1988 to 2000: emergence of Candida parapsilosis","volume":"26","author":"San Miguel","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2019.04.024_bib80","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1469-0691.2005.01268.x","article-title":"Secular trends in nosocomial candidaemia in non-neutropenic patients in an Italian tertiary hospital","volume":"11","author":"Luzzati","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib81","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1439-0507.2005.01134.x","article-title":"Candidaemia in an Irish tertiary referral hospital: epidemiology and prognostic factors","volume":"48","author":"Boo","year":"2005","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.04.024_bib82","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.0933-7407.2003.00907.x","article-title":"Candidaemia in a London teaching hospital: analysis of 128 cases over a 7-year period","volume":"46","author":"Schelenz","year":"2003","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.04.024_bib83","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s10096-003-0890-x","article-title":"Candidemia in a tertiary care hospital: epidemiology and factors influencing mortality","volume":"22","author":"Alonso-Valle","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib84","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10096-002-0822-1","article-title":"Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death","volume":"21","author":"Viudes","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib85","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00005792-200211000-00003","article-title":"Secular trends of candidemia over 12 years in adult patients at a tertiary care hospital","volume":"81","author":"Garbino","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cmi.2019.04.024_bib86","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s100960000325","article-title":"Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital","volume":"19","author":"Luzzati","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib87","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fmicb.2016.00915","article-title":"A\u00a0prospective surveillance study of candidaemia: epidemiology, risk factors, antifungal treatment and outcome in hospitalized patients","volume":"7","author":"Rajendran","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2019.04.024_bib88","series-title":"Voluntary surveillance of candidaemia in England WaNIHPRH. Surveillance of candidaemia in England, Wales and Northern Ireland: 2015","year":"2016"},{"key":"10.1016\/j.cmi.2019.04.024_bib89","series-title":"Voluntary surveillance of candidaemia in England WaNIHPRH. Surveillance of candidaemia in England, Wales and Northern Ireland: 2014","year":"2015"},{"key":"10.1016\/j.cmi.2019.04.024_bib90","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cmi.2015.06.008","article-title":"Twenty-two years of candidaemia surveillance: results from a Norwegian national study","volume":"21","author":"Hesstvedt","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib91","series-title":"Voluntary surveillance of candidaemia in England WaNIHPRH. Surveillance of candidaemia in England, Wales and Northern Ireland: 2013","year":"2014"},{"key":"10.1016\/j.cmi.2019.04.024_bib92","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3201\/eid2007.140087","article-title":"Population-based analysis of invasive fungal infections, France, 2001\u20132010","volume":"20","author":"Bitar","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103916","article-title":"Nosocomial candidemia; risk factors and prognosis revisited; 11 Years experience from a Norwegian secondary hospital","volume":"9","author":"Berdal","year":"2014","journal-title":"Plos One"},{"key":"10.1016\/j.cmi.2019.04.024_bib94","series-title":"Voluntary surveillance of candidaemia in England WaNIHPRH. Surveillance of candidaemia in England, Wales and Northern Ireland: 2012","year":"2013"},{"key":"10.1016\/j.cmi.2019.04.024_bib95","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1469-0691.2008.01954.x","article-title":"Semi-national surveillance of fungaemia in Denmark 2004\u20132006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility","volume":"14","author":"Arendrup","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib96","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1099\/jmm.0.47239-0","article-title":"One year prospective survey of Candida bloodstream infections in Scotland","volume":"56","author":"Odds","year":"2007","journal-title":"J\u00a0Med Microbiol"},{"key":"10.1016\/j.cmi.2019.04.024_bib97","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1128\/JCM.00029-06","article-title":"Candidemia in Norway (1991 to 2003): results from a nationwide study","volume":"44","author":"Sandven","year":"2006","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.04.024_bib98","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10096-004-1267-5","article-title":"Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain","volume":"24","author":"Peman","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib99","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0195-6701(03)00085-9","article-title":"Management and outcome of bloodstream infections due to Candida species in England and Wales","volume":"54","author":"Kibbler","year":"2003","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib100","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1017\/S0950268801005507","article-title":"Emerging trends in the epidemiology of invasive mycoses in England and Wales (1990\u20139)","volume":"126","author":"Lamagni","year":"2001","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib101","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s15010-016-0924-9","article-title":"Nosocomial candidemia in patients admitted to medicine wards compared to other wards: a multicentre study","volume":"44","author":"Luzzati","year":"2016","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2019.04.024_bib102","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s15010-013-0455-6","article-title":"A\u00a01-year prospective survey of candidemia in Italy and changing epidemiology over one decade","volume":"41","author":"Tortorano","year":"2013","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2019.04.024_bib103","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/myc.12077","article-title":"Candidaemia in polish hospitals - a multicentre survey","volume":"56","author":"Nawrot","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.04.024_bib104","doi-asserted-by":"crossref","first-page":"e795","DOI":"10.1111\/j.1439-0507.2011.02027.x","article-title":"Epidemiology and management of candidaemia--a retrospective, multicentre study in five hospitals in the UK","volume":"54","author":"Chalmers","year":"2011","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.04.024_bib105","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10096-005-1321-y","article-title":"Candida species distribution in bloodstream cultures in Lyon, France, 1998\u20132001","volume":"24","author":"Martin","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib106","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10096-004-1103-y","article-title":"Epidemiology of candidaemia in Europe: results of 28-month European confederation of medical mycology (ECMM) hospital-based surveillance study","volume":"23","author":"Tortorano","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib107","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/00365540310017447","article-title":"A\u00a0prospective epidemiological survey of candidaemia in Sweden","volume":"36","author":"Klingspor","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib108","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1469-0691.2002.00446.x","article-title":"Candidemia in French hospitals: incidence rates and characteristics","volume":"8","author":"Richet","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib109","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/myc.12700","article-title":"Candida bloodstream infections in Serbia: first multicentre report of a national prospective observational survey in intensive care units","volume":"61","author":"Arsic Arsenijevic","year":"2018","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.04.024_bib110","first-page":"59","article-title":"ICU-acquired candidaemia in France: epidemiology and temporal trends, 2004\u20132013 - a study from the REA-RAISIN network","volume":"75","author":"Baldesi","year":"2017","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib111","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2334-6-21","article-title":"Epidemiological trends in nosocomial candidemia in intensive care","volume":"6","author":"Bassetti","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib112","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0002-9343(02)01248-2","article-title":"Effects of nosocomial candidemia on outcomes of critically ill patients","volume":"113","author":"Blot","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.cmi.2019.04.024_bib113","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1007\/s00134-003-2002-x","article-title":"Candidemia in critically ill patients: difference of outcome between medical and surgical patients","volume":"29","author":"Charles","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2019.04.024_bib114","first-page":"821","article-title":"Species distribution and antifungal susceptibility of Candida species isolated from blood cultures (2012\u20132015)","volume":"6","author":"Colakoglu","year":"2016","journal-title":"J\u00a0Clinl Anal Med"},{"key":"10.1016\/j.cmi.2019.04.024_bib115","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s11046-017-0155-3","article-title":"Invasive candidiasis in brescia, Italy: analysis of species distribution and antifungal susceptibilities during seven years","volume":"182","author":"De Francesco","year":"2017","journal-title":"Mycopathologia"},{"key":"10.1016\/j.cmi.2019.04.024_bib116","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/jac\/dks480","article-title":"Mortality in patients with early- or late-onset candidaemia","volume":"68","author":"De Rosa","year":"2013","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2019.04.024_bib117","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1213\/ane.0b013e3181607262","article-title":"Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome","volume":"106","author":"Dimopoulos","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.cmi.2019.04.024_bib118","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejim.2017.03.005","article-title":"Assessment of risk factors for candidemia in non-neutropenic patients hospitalized in Internal Medicine wards: a multicenter study","volume":"41","author":"Falcone","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.cmi.2019.04.024_bib119","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/CCM.0000000000002867","article-title":"Initial antifungal strategy reduces mortality in critically ill patients with candidemia: a propensity score-adjusted analysis of a multicenter study","volume":"46","author":"Garnacho-Montero","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cmi.2019.04.024_bib120","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1099\/jmm.0.000505","article-title":"Candidaemia in a tertiary care academic hospital in Italy. The impact of C. parapsilosis complex on the species distribution and antifungal susceptibility","volume":"66","author":"Ghezzi","year":"2017","journal-title":"J\u00a0Med Microbiol"},{"key":"10.1016\/j.cmi.2019.04.024_bib121","first-page":"92","article-title":"Antifungal susceptibility testing of a 10-year collection of Candida spp. isolated from patients with candidemia","volume":"23","author":"Iatta","year":"2011","journal-title":"J\u00a0Chemother"},{"key":"10.1016\/j.cmi.2019.04.024_bib122","first-page":"181","article-title":"Early diagnosis of candidiasis in non-neutropenic critically ill patients","volume":"48","author":"Ibanez-Nolla","year":"2004","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib123","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/myc.12816","article-title":"Epidemiology of fungaemia in Sweden: a nationwide retrospective observational survey","volume":"61","author":"Klingspor","year":"2018","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.04.024_bib124","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0732-8893(99)00096-6","article-title":"Longitudinal 10-year prospective survey of fungaemia in Slovak Republic: trends in etiology in 310 episodes. Slovak Fungaemia study group","volume":"36","author":"Krcmery","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib125","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00134-014-3408-3","article-title":"Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002\u20132010)","volume":"40","author":"Lortholary","year":"2014","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2019.04.024_bib126","first-page":"25","article-title":"Trends in the epidemiology of Candida bloodstream infections in Northern Ireland between January 1984 and December 2000","volume":"45","author":"McMullan","year":"2002","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib127","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s10096-018-3285-8","article-title":"Analyzing candidemia guideline adherence identifies opportunities for antifungal stewardship","volume":"37","author":"Mellinghoff","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib128","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s15010-018-1139-z","article-title":"Evaluation of candidemia and antifungal consumption in a large tertiary care Italian hospital over a 12-year period","volume":"46","author":"Mencarini","year":"2018","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2019.04.024_bib129","first-page":"145","article-title":"Systematic clinical management of patients with candidemia improves survival","volume":"77","author":"Murri","year":"2018","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib130","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/jac\/dks019","article-title":"Epidemiology, species distribution and in\u00a0vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey","volume":"67","author":"Peman","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2019.04.024_bib131","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/CCM.0000000000000221","article-title":"Impact of therapeutic strategies on the prognosis of candidemia in the ICU","volume":"42","author":"Puig-Asensio","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cmi.2019.04.024_bib132","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/myc.12661","article-title":"Changes in the distribution of colonising and infecting Candida spp. isolates, antifungal drug consumption and susceptibility in a French intensive care unit: a 10-year study","volume":"60","author":"Sasso","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.04.024_bib133","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2334-6-80","article-title":"Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links","volume":"6","author":"Sendid","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib134","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10096-016-2841-3","article-title":"Epidemiology and reporting of candidaemia in Belgium: a multi-centre study","volume":"36","author":"Trouve","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib135","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.ajic.2017.02.022","article-title":"Risk factors, characteristics, and outcomes of candidemia in an adult intensive care unit in Turkey","volume":"45","author":"Tukenmez Tigen","year":"2017","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.cmi.2019.04.024_bib136","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/myc.12618","article-title":"Epidemiology, species distribution, clinical characteristics and mortality of candidaemia in a tertiary care university hospital in Turkey, 2007\u20132014","volume":"60","author":"Yesilkaya","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.04.024_bib137","doi-asserted-by":"crossref","first-page":"R62","DOI":"10.1186\/cc11307","article-title":"Comparison of the epidemiology, risk factors, outcome and degree of organ failures of patients with candidemia acquired before or during ICU treatment","volume":"16","author":"Ylipalosaari","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2019.04.024_bib138","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/myc.12582","article-title":"Epidemiology and cost implications of candidemia, a 6-year analysis from a developing country","volume":"60","author":"Kilic","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.04.024_bib139","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1439-0507.2007.01452.x","article-title":"Observational study on candidaemia at a university hospital in southern Italy from 1998 to 2004","volume":"51","author":"Caggiano","year":"2008","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.04.024_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2014.08.011","article-title":"Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006\u20132008)","volume":"21","author":"Klingspor","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.04.024_bib141","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2165\/00003495-200868140-00002","article-title":"Patients at high risk of invasive fungal infections: when and how to treat","volume":"68","author":"Ruping","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.cmi.2019.04.024_bib142","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2019.04.024_bib143","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/cid\/cis021","article-title":"Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials","volume":"54","author":"Andes","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib144","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/archinte.1989.00390100145030","article-title":"Risk factors for hospital-acquired candidemia. A matched case-control study","volume":"149","author":"Wey","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cmi.2019.04.024_bib145","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/TCRM.S40160","article-title":"Epidemiology and risk factors for invasive candidiasis","volume":"10","author":"Yapar","year":"2014","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.cmi.2019.04.024_bib146","first-page":"445","article-title":"Epidemiology of invasive candidiasis","volume":"16","author":"Arendrup","year":"2010","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.cmi.2019.04.024_bib147","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/civ293","article-title":"Epidemiology and outcome of fungemia in a cancer cohort of the infectious diseases group (IDG) of the European organization for research and treatment of cancer (EORTC 65031)","author":"Cornely","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib148","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1128\/JCM.02117-09","article-title":"Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion","volume":"48","author":"Pfaller","year":"2010","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.04.024_bib149","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/JCM.01398-10","article-title":"Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009)","volume":"49","author":"Pfaller","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.04.024_bib150","doi-asserted-by":"crossref","first-page":"e954","DOI":"10.1016\/j.ijid.2010.04.006","article-title":"Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review","volume":"14","author":"Falagas","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.024_bib151","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/myc.12207","article-title":"Our 2014 approach to candidaemia","volume":"57","author":"Koehler","year":"2014","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.04.024_bib152","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00080-18","article-title":"The misidentification of Candida auris using RapID Yeast Plus, a commercial, biochemical enzyme-based manual rapid identification system","author":"Snayd","year":"2018","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.04.024_bib153","article-title":"Meta-analysis of observational studies with unmeasured confounders","volume":"8","author":"McCandless","year":"2012","journal-title":"Int J Biostat"},{"key":"10.1016\/j.cmi.2019.04.024_bib154","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/aje\/kwm189","article-title":"Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles","volume":"166","author":"Shrier","year":"2007","journal-title":"Am J Epidemiol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19302022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19302022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:22:34Z","timestamp":1761117754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X19302022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":154,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1198743X19302022"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2019.04.024","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2019.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}